A US Congressional report summarizing issues facing the dietary supplement industry – signaling a possible legislative hearing on the horizon – notes various “limitations” in the US Food and Drug Administration’s current authority over supplements.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?